Suppr超能文献

PARP 介导的修复、同源重组和单链缺口的备用非同源末端连接样修复。

PARP-mediated repair, homologous recombination, and back-up non-homologous end joining-like repair of single-strand nicks.

机构信息

Division of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA 98109, USA.

出版信息

DNA Repair (Amst). 2013 Jul;12(7):529-34. doi: 10.1016/j.dnarep.2013.04.004. Epub 2013 May 16.

Abstract

Double-strand breaks (DSBs) in chromosomal DNA can induce both homologous recombination (HR) and non-homologous end-joining (NHEJ). Recently we showed that single-strand nicks induce HR with a significant reduction in toxicity and mutagenic effects associated with NHEJ. To further investigate the differences and similarities of DSB- and nick-induced repair, we used an integrated reporter system in human cells to measure HR and NHEJ produced by the homing endonuclease I-AniI and a designed 'nickase' variant that nicks the same target site, focusing on the PARP and HR repair pathways. PARP inhibitors, which block single-strand break repair, increased the rate of nick-induced HR up to 1.7-fold but did not affect DSB-induced HR or mutNHEJ. Additionally, expression of the PALB2 WD40 domain in trans acted as a dominant-negative inhibitor of both DSB- and nick-induced HR, sensitized cells to PARP inhibition, and revealed an alternative mutagenic repair pathway for nicks. Thus, while both DSB- and nick-induced HR use a common pathway, their substrates are differentially processed by cellular factors. These results also suggest that the synthetic lethality of PARP and BRCA may be due to repair of nicks through an error prone, NHEJ-like mechanism that is active when both PARP and HR pathways are blocked.

摘要

双链断裂(DSBs)在染色体 DNA 中可以诱导同源重组(HR)和非同源末端连接(NHEJ)。最近我们发现,单链切口诱导 HR,同时显著降低了与 NHEJ 相关的毒性和突变效应。为了进一步研究 DSB 和切口诱导修复的差异和相似之处,我们使用人细胞中的整合报告系统来测量同源内切酶 I-AniI 产生的 HR 和 NHEJ 以及设计的“切口酶”变体在相同靶位点产生的 HR 和 NHEJ,重点关注 PARP 和 HR 修复途径。PARP 抑制剂可阻断单链断裂修复,将切口诱导的 HR 率提高了 1.7 倍,但不影响 DSB 诱导的 HR 或 mutNHEJ。此外,转染表达 PALB2 WD40 结构域作为 DSB 和切口诱导 HR 的显性负抑制剂,使细胞对 PARP 抑制剂敏感,并揭示了切口的另一种突变修复途径。因此,虽然 DSB 和切口诱导的 HR 都使用共同的途径,但它们的底物被细胞因子以不同的方式处理。这些结果还表明,PARP 和 BRCA 的合成致死性可能是由于通过易错的、类似于 NHEJ 的机制修复切口,当 PARP 和 HR 途径都被阻断时,该机制是活跃的。

相似文献

1
PARP-mediated repair, homologous recombination, and back-up non-homologous end joining-like repair of single-strand nicks.
DNA Repair (Amst). 2013 Jul;12(7):529-34. doi: 10.1016/j.dnarep.2013.04.004. Epub 2013 May 16.
2
A role for human homologous recombination factors in suppressing microhomology-mediated end joining.
Nucleic Acids Res. 2016 Jul 8;44(12):5743-57. doi: 10.1093/nar/gkw326. Epub 2016 Apr 29.
3
Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks.
Mutat Res Genet Toxicol Environ Mutagen. 2021 Jul;867:503372. doi: 10.1016/j.mrgentox.2021.503372. Epub 2021 Jun 12.
4
CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair.
Sci Adv. 2017 May 24;3(5):e1601898. doi: 10.1126/sciadv.1601898. eCollection 2017 May.
5
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
Nucleic Acids Res. 2006;34(21):6170-82. doi: 10.1093/nar/gkl840. Epub 2006 Nov 6.
6
CRISPR/Cas9-Induced Double-Strand Break Repair in Arabidopsis Nonhomologous End-Joining Mutants.
G3 (Bethesda). 2017 Jan 5;7(1):193-202. doi: 10.1534/g3.116.035204.
7
Distinct genetic control of homologous recombination repair of Cas9-induced double-strand breaks, nicks and paired nicks.
Nucleic Acids Res. 2016 Jun 20;44(11):5204-17. doi: 10.1093/nar/gkw179. Epub 2016 Mar 21.
8
Microhomology-mediated end joining: Good, bad and ugly.
Mutat Res. 2018 May;809:81-87. doi: 10.1016/j.mrfmmm.2017.07.002. Epub 2017 Jul 16.
10
Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
Nucleic Acids Res. 2014 Jun;42(10):6380-92. doi: 10.1093/nar/gku298. Epub 2014 Apr 19.

引用本文的文献

1
PARP (Poly ADP-ribose Polymerase) Family in Health and Disease.
MedComm (2020). 2025 Sep 1;6(9):e70314. doi: 10.1002/mco2.70314. eCollection 2025 Sep.
2
Bibliometric analysis of research trends on the combination of immune checkpoint inhibitors and PARP inhibitors in solid tumors.
Heliyon. 2024 Jan 10;10(2):e24452. doi: 10.1016/j.heliyon.2024.e24452. eCollection 2024 Jan 30.
3
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
Nat Commun. 2022 Dec 14;13(1):7748. doi: 10.1038/s41467-022-35378-z.
4
The Role of DNA Repair in Genomic Instability of Multiple Myeloma.
Int J Mol Sci. 2022 May 19;23(10):5688. doi: 10.3390/ijms23105688.
5
Different DNA repair pathways are involved in single-strand break-induced genomic changes in plants.
Plant Cell. 2021 Nov 4;33(11):3454-3469. doi: 10.1093/plcell/koab204.
7
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.
Blood Adv. 2021 Mar 9;5(5):1137-1153. doi: 10.1182/bloodadvances.2020001996.
8
Novel allosteric PARP1 inhibitors for the treatment of BRCA-deficient leukemia.
Med Chem Res. 2020 Jun;29(6):962-978. doi: 10.1007/s00044-020-02537-0. Epub 2020 Apr 19.
9
Advances and perspectives of PARP inhibitors.
Exp Hematol Oncol. 2019 Nov 11;8:29. doi: 10.1186/s40164-019-0154-9. eCollection 2019.
10
Can synthetic lethality approach be used with DNA repair genes for primary and secondary MDS?
Med Oncol. 2019 Oct 30;36(12):99. doi: 10.1007/s12032-019-1324-7.

本文引用的文献

1
Drug candidates derailed in case of mistaken identity.
Nature. 2012 Mar 28;483(7391):519. doi: 10.1038/483519a.
2
Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1.
Cancer Res. 2012 Jun 1;72(11):2814-21. doi: 10.1158/0008-5472.CAN-11-3417. Epub 2012 Mar 23.
3
Topoisomerase I poisoning results in PARP-mediated replication fork reversal.
Nat Struct Mol Biol. 2012 Mar 4;19(4):417-23. doi: 10.1038/nsmb.2258.
4
Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects.
Nucleic Acids Res. 2012 Jul;40(12):5560-8. doi: 10.1093/nar/gks179. Epub 2012 Feb 28.
5
Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro.
Clin Cancer Res. 2012 Mar 15;18(6):1655-62. doi: 10.1158/1078-0432.CCR-11-2890. Epub 2012 Jan 30.
6
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.
Clin Cancer Res. 2012 Jan 15;18(2):510-23. doi: 10.1158/1078-0432.CCR-11-1973. Epub 2011 Nov 29.
7
DNA nicks promote efficient and safe targeted gene correction.
PLoS One. 2011;6(9):e23981. doi: 10.1371/journal.pone.0023981. Epub 2011 Sep 1.
8
The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings.
Mol Oncol. 2011 Aug;5(4):387-93. doi: 10.1016/j.molonc.2011.07.001. Epub 2011 Jul 22.
9
Tracking genome engineering outcome at individual DNA breakpoints.
Nat Methods. 2011 Jul 10;8(8):671-6. doi: 10.1038/nmeth.1648.
10
PARP inhibitors stumble in breast cancer.
Nat Biotechnol. 2011 May;29(5):373-4. doi: 10.1038/nbt0511-373.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验